MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

PHR.US

24.82

-5.12%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

PHR.US

24.82

-5.12%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

PHR.US

24.82

-5.12%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

PHR.US

24.82

-5.12%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

PHR.US

24.82

-5.12%↓

Search

Agilent Technologies Inc

Gesloten

SectorGezondheidszorg

109.71 -5.41

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

109.67

Max

115.92

Belangrijke statistieken

By Trading Economics

Inkomsten

-33M

318M

Verkoop

-20M

1.7B

K/W

Sectorgemiddelde

26.83

63.778

EPS

1.31

Dividendrendement

0.85

Winstmarge

18.917

Werknemers

17,900

EBITDA

59M

467M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+32.05% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.85%

2.39%

Volgende Winsten

28 mei 2025

Volgende dividenddatum

23 apr 2025

Volgende Ex Dividend datum

30 jun 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-9.9B

33B

Vorige openingsprijs

115.12

Vorige sluitingsprijs

109.71

Nieuwssentiment

By Acuity

29%

71%

87 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Agilent Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2024, 09:29 UTC

Winsten

UBS Net Profit Beats Expectations on Credit Suisse Savings -- 3rd Update

14 jan 2025, 13:05 UTC

Acquisities, Fusies, Overnames

Topicus.com in Agreement to Acquire Cipal Schaubroeck in Belgium >

30 mei 2024, 18:36 UTC

Winsten

These Stocks Are Moving the Most Today: Salesforce, UiPath, HP Inc., Best Buy, Kohl's, Foot Locker, C3.ai, Nutanix, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Agilent Technologies Inc Prognose

Koersdoel

By TipRanks

32.05% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 153.17 USD  32.05%

Hoogste 160 USD

Laagste 138 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Agilent Technologies Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

6

Buy

3

Hold

0

Sell

Technische score

By Trading Central

113.36 / 119.6898Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

87 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.